A patient with hypertension previously treated with telmisartan/amlodipine now has borderline low systolic blood pressure, prolonged capillary refill, intermittent non‑exertional chest pain, and is taking Yaz (drospirenone/ethinyl estradiol), escitalopram, quetiapine, and levothyroxine; what is the most likely diagnosis and what management steps should be taken?

Hypertension with Possible Medication-Related Complications

Continue the current telmisartan/amlodipine 40/20 mg regimen without dose reduction, but immediately investigate the prolonged capillary refill time and intermittent chest pain as these are concerning signs that may indicate inadequate tissue perfusion or cardiac ischemia rather than medication side effects.

Blood Pressure Assessment

The patient's blood pressure readings are not concerning for overtreatment:

• Office readings of 130/90 mmHg and 140/90 mmHg on recheck indicate inadequate control by current guideline standards 1, 2
• The 2025 AHA/ACC guidelines recommend targeting systolic BP of 120-129 mmHg in most adults when well tolerated 1
• The 2024 ESC guidelines similarly recommend targeting systolic BP of 120-129 mmHg to reduce cardiovascular risk 2
• Home readings of 110-120 mmHg systolic are appropriate and within target range, not dangerously low 1, 2
• The current dose of telmisartan/amlodipine 40/20 mg is a low-to-moderate dose with room for escalation if needed 3

Critical Red Flags Requiring Immediate Evaluation

The following findings are not explained by blood pressure medications and warrant urgent investigation:

Prolonged Capillary Refill Time (>2 seconds)

• This suggests inadequate peripheral perfusion and is abnormal in a young patient 2
• Possible etiologies include:
  • Hypovolemia or dehydration
  • Cardiac output compromise
  • Peripheral vascular disease (less likely given age, but strong family history of aneurysms)
  • Severe anemia
  • Hypothyroidism (though patient is on levothyroxine)

Intermittent Non-Exertional Chest Pain

• Non-exertional chest pain in a hypertensive patient with multiple cardiovascular risk factors requires cardiac evaluation 1
• Risk factors present:
  • Hypertension (inadequately controlled)
  • Strong family history (father with diabetes, prostate cancer, aneurysms; both parents with hypertension)
  • PCOS (associated with increased cardiovascular risk)
  • Possible metabolic syndrome given PCOS
  • Use of combined oral contraceptives (Yaz contains drospirenone/ethinyl estradiol, which carries thrombotic risk)

Most Likely Diagnoses

Primary Diagnosis: Inadequately Controlled Hypertension

• Office BP remains elevated at 130-140/90 mmHg despite treatment 1, 2
• Patient requires medication continuation and possible escalation, not reduction 3

Secondary Concerns Requiring Workup:

1. Cardiac ischemia or structural heart disease - explaining chest pain and possibly reduced perfusion
2. Medication interaction or adverse effect from Yaz - combined oral contraceptives can increase thrombotic risk and may affect cardiovascular function
3. Thyroid dysfunction - despite levothyroxine, TSH should be rechecked as hypothyroidism can cause poor perfusion
4. Anemia - can cause both poor perfusion and chest discomfort

Immediate Next Steps

1. Cardiovascular Evaluation (Urgent)

• ECG immediately to assess for ischemic changes, arrhythmias, or structural abnormalities 1
• Troponin if any concern for acute coronary syndrome
• Echocardiogram to assess cardiac function and rule out structural disease
• Exercise stress test or coronary CT angiography if initial workup suggests ischemia 1

2. Laboratory Assessment

• Complete blood count to rule out anemia
• TSH and free T4 to ensure adequate thyroid replacement
• Fasting lipid panel and glucose given PCOS and family history of diabetes 1
• Basic metabolic panel to assess electrolytes and renal function (telmisartan can affect potassium and renal function) 3
• Consider screening for secondary hypertension given young age and family history: plasma aldosterone/renin ratio, renal ultrasound with Doppler 1

3. Medication Review

• Continue telmisartan/amlodipine 40/20 mg - BP is not at goal and home readings are appropriate 1, 2, 3
• Reassess Yaz (drospirenone/ethinyl estradiol) - combined oral contraceptives increase cardiovascular and thrombotic risk, particularly in hypertensive patients 1
  • Consider switching to progestin-only contraception or non-hormonal methods
  • Drospirenone also has antimineralocorticoid activity and can increase potassium, potentially interacting with telmisartan 3
• Review quetiapine and escitalopram - ensure doses are appropriate and not contributing to orthostatic changes

4. Blood Pressure Management Strategy

• Do not reduce antihypertensive dose - patient is not at goal 1, 2
• If BP remains >130/80 mmHg after 2-4 weeks and cardiac workup is reassuring, consider escalating to telmisartan/amlodipine 40/40 mg or 80/20 mg 3
• If three-drug therapy becomes necessary, add a thiazide-like diuretic (chlorthalidone or indapamide) 1, 2
• Single-pill combinations improve adherence and are preferred 2, 4

Common Pitfalls to Avoid

1. Do not attribute prolonged capillary refill to blood pressure medications alone - this finding suggests inadequate perfusion and requires investigation 2

2. Do not reduce antihypertensive therapy based on home readings of 110-120 mmHg systolic - these readings are at goal, and office readings remain elevated 1, 2

3. Do not dismiss non-exertional chest pain - while less specific than exertional symptoms, it still requires cardiac evaluation in a patient with cardiovascular risk factors 1

4. Do not overlook the thrombotic risk of combined oral contraceptives - Yaz should be reconsidered in a hypertensive patient with chest pain 1

5. Do not assume adequate thyroid replacement without recent TSH - hypothyroidism can cause poor perfusion and cardiovascular symptoms

Follow-Up Plan

• Urgent cardiology referral if any abnormalities on ECG or troponin
• Recheck BP in 2-4 weeks after addressing acute concerns 1, 2
• Annual BP monitoring minimum given history of hypertension 1
• Lifestyle modifications: reduce fast food intake, maintain healthy diet, regular physical activity 2
• Consider aspirin for cardiovascular risk reduction if cardiac evaluation reveals significant risk 1